The Effect of Kidney Function and Cardiovascular and Anti-Inflammatory Comedications on the Serum Concentration of Risperidone under Naturalistic Conditions
Pharmacopsychiatry · 01.03.2026 · 59 (02) · 66-73
DOI: 10.1055/a-2764-4939 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacopsychiatry, erschienen am 01.03.2026. Verfasst von Meike Kohler und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Psychosomatics and Psychotherapy, Centre of Mental Health, University Hospital of Würzburg, Würzburg, Germany. Hauptthemen laut MEDLINE: Risperidone, Antipsychotic Agents, Kidney, Anti-Inflammatory Agents.
Abstract (Originalsprache)
Introduction
Polypharmacy has an important role in psychiatry, as the kidney function can be affected by medication. Risperidone is metabolized hepatically to 9-hydroxyrisperidone and excreted renally. Here, we study how serum concentrations of risperidone, 9-hydroxyrisperidone and active moiety (risperidone+9-hydroxyrisperidone) are related to impairment of kidney function and potentially interacting comedications that affect renal functions ((1) nonsteroidal anti-inflammatory drugs, (2) angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers, and (3) diuretics).
Methods
In this retrospective study, data from risperidone-treated inpatients (2015–2020, n=517) at the University Hospital of Würzburg were analyzed. Routine therapeutic drug monitoring was performed at trough levels at a steady-state. Groups were compared by means of the Kruskal–Wallis test. To correct for confounding parameters, additional multiple linear regression modeling was performed.
Results
After correction for age, sex, body mass index and the respective interaction between the estimated glomerular filtration rate and the number of interacting drugs, the dose-corrected serum concentration of 9-hydroxyrisperidone and the active moiety of risperidone were positively associated with the number of interacting drugs. The active moiety was negatively associated with the estimated glomerular filtration rate.
Discussion
Our data suggest that renal functions and the number of interacting drugs influence the pharmacokinetics of risperidone. Previous studies often explained the increasing serum concentration with age as a surrogate, whereas our results suggest that the kidney function and comedication affecting kidney function might be more relevant. When prescribing risperidone, especially in patients with renal impairment or co-medicated with interacting drugs, we suggest to start with lower starting doses and recommend monitoring serum concentrations to prevent overdosing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, Psychosomatics and Psychotherapy, Centre of Mental Health, University Hospital of Würzburg, Würzburg, Germany.
- Institute of Clinical Epidemiology and Biometry, Julius-Maximilians-Universität Würzburg, Würzburg, Germany.
- Department of Psychiatry and Psychotherapy, Social Foundation Bamberg, Teaching Hospital of the University of Erlangen, Bamberg, Germany.
ORCID-Profile: Maike Scherf-Clavel
Zitieren
APA
Kohler, M., Deckert, J., Walther, S., Unterecker, S., & Scherf-Clavel, M. (2026). The Effect of Kidney Function and Cardiovascular and Anti-Inflammatory Comedications on the Serum Concentration of Risperidone under Naturalistic Conditions. Pharmacopsychiatry, 59(02), 66-73. https://doi.org/10.1055/a-2764-4939
Vancouver
Kohler M, Deckert J, Walther S, Unterecker S, Scherf-Clavel M. The Effect of Kidney Function and Cardiovascular and Anti-Inflammatory Comedications on the Serum Concentration of Risperidone under Naturalistic Conditions. Pharmacopsychiatry. 2026;59(02):66-73. doi:10.1055/a-2764-4939
BibTeX
@article{Kohler2026,
author = {Kohler, Meike and Deckert, Jürgen and Walther, Sebastian and Unterecker, Stefan and Scherf-Clavel, Maike},
title = {The Effect of Kidney Function and Cardiovascular and Anti-Inflammatory Comedications on the Serum Concentration of Risperidone under Naturalistic Conditions},
journal = {Pharmacopsychiatry},
year = {2026},
volume = {59},
number = {02},
pages = {66--73},
doi = {10.1055/a-2764-4939}
}
EUVIMED